The network pharmacology highlighted this signaling pathway and our results indicate that ABS can upregulate the phosphorylation of PI3K, Akt, and GSK3β in the ABS treatment group compared to the model group, and this change is similar to other natural products improving obesity [60]. The gene discussed is AKT1; the disease is Obesity.